As of 2024-12-12, the Intrinsic Value of Generic Sweden AB (publ) (GENI.ST) is
61.64 SEK. This GENI.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 50.60 SEK, the upside of Generic Sweden AB (publ) is
21.80%.
The range of the Intrinsic Value is 48.04 - 87.25 SEK
61.64 SEK
Intrinsic Value
GENI.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
48.04 - 87.25 |
61.64 |
21.8% |
DCF (Growth 10y) |
63.96 - 115.16 |
81.77 |
61.6% |
DCF (EBITDA 5y) |
23.38 - 34.44 |
27.79 |
-45.1% |
DCF (EBITDA 10y) |
36.89 - 52.21 |
43.04 |
-14.9% |
Fair Value |
46.39 - 46.39 |
46.39 |
-8.32% |
P/E |
20.52 - 32.62 |
26.98 |
-46.7% |
EV/EBITDA |
10.15 - 22.36 |
17.39 |
-65.6% |
EPV |
36.17 - 49.62 |
42.89 |
-15.2% |
DDM - Stable |
15.44 - 43.62 |
29.53 |
-41.6% |
DDM - Multi |
32.68 - 69.82 |
44.31 |
-12.4% |
GENI.ST Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
621.98 |
Beta |
0.68 |
Outstanding shares (mil) |
12.29 |
Enterprise Value (mil) |
608.67 |
Market risk premium |
5.10% |
Cost of Equity |
7.12% |
Cost of Debt |
5.00% |
WACC |
5.54% |